Filing Details
- Accession Number:
- 0001127602-21-009281
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-03 19:08:41
- Reporting Period:
- 2021-03-01
- Accepted Time:
- 2021-03-03 19:08:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1635424 | M Terence Berge | C/O Conmed Corporation 11311 Concept Boulevard Largo FL 33773 | Vp-Corporate Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-03-01 | 3,860 | $39.87 | 4,864 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-01 | 3,860 | $122.77 | 1,004 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-03-01 | 2,800 | $41.93 | 3,804 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-01 | 2,800 | $122.53 | 1,004 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-03-01 | 2,700 | $59.96 | 3,704 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-01 | 2,700 | $122.50 | 1,004 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-03-01 | 5,400 | $78.76 | 6,404 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-01 | 5,400 | $122.50 | 1,004 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-03-01 | 2,550 | $97.69 | 3,554 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-01 | 2,550 | $122.50 | 1,004 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Options To Purchase Common Stock | Disposition | 2021-03-01 | 3,860 | $0.00 | 3,860 | $39.87 |
Common Stock | Options To Purchase Common Stock | Disposition | 2021-03-01 | 2,800 | $0.00 | 2,800 | $41.93 |
Common Stock | Options To Purchase Common Stock | Disposition | 2021-03-01 | 2,700 | $0.00 | 2,700 | $59.96 |
Common Stock | Options To Purchase Common Stock | Disposition | 2021-03-01 | 5,400 | $0.00 | 5,400 | $78.76 |
Common Stock | Options To Purchase Common Stock | Disposition | 2021-03-01 | 2,550 | $0.00 | 2,550 | $97.69 |
Common Stock | Options To Purchase Common Stock | Acquisiton | 2021-03-01 | 12,000 | $0.00 | 12,000 | $122.55 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2026-03-01 | No | 4 | M | Direct | |
2,800 | 2031-03-01 | No | 4 | M | Direct | |
5,400 | 2028-03-01 | No | 4 | M | Direct | |
8,100 | 2029-03-01 | No | 4 | M | Direct | |
10,200 | 2030-03-02 | No | 4 | M | Direct | |
12,000 | 2031-03-01 | No | 4 | A | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.66 to $122.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.50 to $122.62. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
- The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period